Mazabraud Yann 4
4 · RHYTHM PHARMACEUTICALS, INC. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Mazabraud Yann
EVP, Head of International
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-04-15−2,500→ 7,500 total→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2025-04-14+10,375→ 32,995 total - Exercise/Conversion
Common Stock
2025-04-15+11,405→ 44,400 total - Exercise/Conversion
Restricted Stock Units
2025-04-14−10,375→ 20,750 total→ Common Stock (10,375 underlying) - Exercise/Conversion
Restricted Stock Units
2025-04-15−8,905→ 0 total→ Common Stock (8,905 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
- [F3]The restricted stock units have vested in full on April 15, 2025. The restricted stock units have no expiration date.
- [F4]The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.